38204-35-2

Basic information

• Product Name: (4-acetylamino-thiobenzoylsulfanyl)-acetic acid
• CAS NO: 38204-35-2
• Molecular Weight: 269.345
• Mol File: 38204-35-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (4-acetylamino-thiobenzoylsulfanyl)-acetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (4-acetylamino-thiobenzoylsulfanyl)-acetic acid(38204-35-2)
• EPA Substance Registry System: (4-acetylamino-thiobenzoylsulfanyl)-acetic acid(38204-35-2)

Safety Data

• Hazardous Substances Data: 38204-35-2(Hazardous Substances Data)

Upstream product

• 42285-11-0 1-(4-acetylamino-thiobenzoyl)-piperidine 
• 79-08-3 bromoacetic acid 

Downstream Products

• 144841-93-0 N-[1-(4-Acetylamino-phenyl)-1-methylsulfanyl-meth-(Z)-ylidene]-N,N'-dimethyl-hydrazinium; iodide 
• 144841-88-3 C₉H₁₅N₅*2ClH 
• 144841-89-4 C₁₀H₁₆N₄*2ClH 
• 143538-75-4 4-(1,2-Dimethyl-6-phenyl-1,2-dihydro-[1,2,4,5]tetrazin-3-yl)-phenylamine 
• 94626-71-8 4-Acetamino-thiobenzoesaeure-(N².N²-dimethyl-hydrazid) 
• 92765-94-1 N-(4-[1,2,3,4]thiatriazol-5-yl-phenyl)-acetamide 
• 27249-71-4 4-Acetamidothiobenzoesaeureallylthioester 
• 83070-46-6 4-acetylamino-thiobenzoic acid hydrazide 
• 27249-70-3 4-Acetamidothiobenzoesaeureethylthioester 

Relevant articles and documents

Thiadizines

Novel heterocyclic compounds of the formula: STR1 wherein either X is --CR1 R2 -- and Y is oxygen, sulphur or --NR3, wherein R1, R2 and R3, which may be the same or different, each is hydrogen or alkyl of up to 4 carbon atoms; or X is oxygen, sulphur or --NH-- and Y is --CH2 --; wherein R4 and R5, which may be the same or different, each is hydrogen, cyano, nitro, amino or hydroxy, or alkylthio of up to 4 carbon atoms, or has various other meanings defined in claim 1, provided that R4 and R5 are not both hydrogen; or wherein R4 and R5 are joined together such that with the benzene ring A they form a benzheterocyclic ring as defined in claim 1; and therein the benzene ring A may optionally bear one or more further substituents; or a salt thereof where appropriate. These compounds possess cardiotonic properties, and some of them possess peripheral vasodilator properties, and they are useful for the treatment of acute or chronic heart failure. Representative of the compounds is N,N-dimethyl-p-(5,6-dihydro-5-oxo-4H-1,3,4-thiadiazin-2-yl)benzamide. Also disclosed are processes for the manufacture of the compounds and pharmaceutical compositions containing them.